Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Administered as a once-weekly subcutaneous injection, Ozempic has shown benefits in glycaemic control and, in the SUSTAIN-6 trial, demonstrated cardiovascular outcomes, though its licensed indication remains for glycaemic control
Learn to listen to your bodys signals instead of eating out of habit or boredom
Nausea, constipation, and mild stomach upset occur in many patients during dose escalation but typically resolve within 24 weeks as the body adapts
It is well-absorbed orally and has a documented clinical track record but it also has a documented GI side-effect profile
US$ 20.56
US$ 23.45
US$ 23.87
US$ 29.74
US$ 27.50
US$ 23.39
US$ 22.32
US$ 28.86
US$ 24.84
US$ 21.59
